Albert Einstein College of Medicine
The Dawlaty Laboratory at the Genetics Department and the Institute for Stem Cell and Regenerative Medicine Research of Albert Einstein College of Medicine in New York City is seeking a highly motivated postdoctoral fellow with expertise in bioinformatics to study the epigenetic basis of gene expression in stem cells and cancer using next generation sequencing and systems biology approaches. Our research focuses on understanding the epigenetic mechanisms of gene regulation in stem cells, development and cancer with an emphasis on the role of DNA modifying enzymes. We utilize embryonic stem cells, induced pluripotent stem cells and mice as model systems and combine bioinformatics, cellular and molecular approaches to study how DNA modifying enzymes (Tet enzymes) reshape the epigenome and regulate gene expression programs in development and cancer. For more details on our research see previous work (Dawlaty et al Cell Stem Cell 2011, Dawlaty et al Developmental Cell 2013, Dawlaty et al Developmental Cell 2014, Rudenko & Dawlaty et al Neuron 2013, Cimmino & Dawlaty et al Nature Immunology 2015) or visit our websites http://www.einstein.yu.edu/faculty/14514/meelad-dawlaty/
The Scientific Community:
Among the top tier of the nation's medical schools to receive NIH funding, Albert Einstein College of Medicine offers a highly interactive and stimulating academic environment for scientists in training. Additionally, candidate's research will benefit from the highly interactive environment within the Gottesman Institute for Stem Cell and Regenerative Medicine, the Department of Genetics, Developmental and Molecular Biology, the Cancer Center and throughout the college. We are located in a pleasant residential area in the northeast corner of New York City with an easy commute to Manhattan and the suburbs of Westchester County. We offer competitive salary and benefit packages with optional housing on campus.
The Albert Einstein College of Medicine is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, protected veteran or disabled status, or genetic information.
Ph.D. or MD or equivalent degree
Prior experience in bioinformatics (mainly genome-wide analyses of DNA and histone modifications, gene expression profiling and high through put sequencing data such as RNA-seq, MeDIP-seq and ChIP-seq) is an absolute requirement for this position.
Prior experience with general molecular biology skills and tissue culture (or willingness to learn these skills) is preferred.
To apply, please email your CV and a cover letter summarizing your experience, along with the contact information of two references to email@example.com
addressed to Meelad Dawlaty Ph.D., Assistant Professor of Genetics, Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY
early plans As early as 1945, Yeshiva University President Dr. Samuel Belkin envisioned the creation of a new medical school. Encouraged by influential public figures, he persuaded the Board of Trustees to initiate discussions with the New York State Board of Regents to amend the University’s charter to include the granting of the degree of Doctor of Medicine, discussions that were successfully completed on December 15, 1950. In June, 1951, Dr. Belkin and New York City Mayor Vincent Impellitteri entered into an agreement whereby the professional care of all patients in the 1,400-bed Bronx Municipal Hospital Center then under construction would be the responsibility of the faculty of the College of Medicine. On March 15, 1953, the day following his 74th birthday, Professor Albert Einstein formally agreed to permit his name to be used for the first medical school to be built in New York City since 1897. Ground was broken for the first building, now known as the Leo Forchheimer Medical Sciences Building, in October, 1953. Its partial completion was effected in time to welcome the first class of 53 men and three women medical students and about 75 faculty members on September 12, 1955. Entering class size was progressively increased to its present number of 180 students. The total student body now numbers well over 800, including postgraduates attending the Sue Golding Graduate Division of Medical Sciences and the Belfer Institute for Advanced Biomedical Studies.